UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$440M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 3 |
CRH
CRH
|
+$275M |
| 4 |
Advanced Micro Devices
AMD
|
+$228M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$538M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$473M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$397M |
| 4 |
Microsoft
MSFT
|
+$366M |
| 5 |
UnitedHealth
UNH
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.43% |
| 2 | Financials | 6.7% |
| 3 | Healthcare | 6.28% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Industrials | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$309M
| $202K | ﹤0.01% |
11,542
-7,113
| -38% | -$133K |
|
|
HLVX
5377
DELISTED
HilleVax
HLVX
| $201K | ﹤0.01% |
14,967
-299
| -2% | -$4.21K |
|
|
LONA
5378
LeonaBio Inc
LONA
$74.8M
| $201K | ﹤0.01% |
9,950
+7,120
| +252% | +$182K |
|
5379
LCNB Corp
LCNB
$283M
| $201K | ﹤0.01% |
14,082
-418
| -3% | -$6.53K |
|
5380
Xenon Pharmaceuticals
XENE
$6.03B
| $201K | ﹤0.01% |
5,882
+1,003
| +21% | +$37.5K |
|
|
MOFG
5381
DELISTED
MidWestOne Financial Group
MOFG
| $201K | ﹤0.01% |
9,876
-92
| -0.9% | -$2.02K |
|
|
SHCR
5382
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $201K | ﹤0.01% |
213,574
+14,861
| +7% | +$17.7K |
|
5383
AST SpaceMobile
ASTS
$21.3B
| $200K | ﹤0.01% |
52,627
-1,729
| -3% | -$6.98K |
|
5384
BioXcel Therapeutics
BTAI
$36.7M
| $199K | ﹤0.01% |
4,913
-2,021
| -29% | -$204K |
|
5385
PLAYSTUDIOS Inc
MYPS
$63.1M
| $198K | ﹤0.01% |
62,351
-6,045
| -9% | -$24K |
|
5386
ClearPoint Neuro
CLPT
$468M
| $198K | ﹤0.01% |
39,573
-3,988
| -9% | -$23.7K |
|
5387
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
| $198K | ﹤0.01% |
10,397
-200
| -2% | -$3.86K |
|
5388
RCM Technologies
RCMT
$248M
| $195K | ﹤0.01% |
10,004
-4,088
| -29% | -$80.3K |
|
5389
1-800-Flowers.com
FLWS
$262M
| $195K | ﹤0.01% |
27,823
+8,172
| +42% | +$61.4K |
|
5390
Vertex
VERX
$2.06B
| $195K | ﹤0.01% |
8,428
-2,763
| -25% | -$56.9K |
|
5391
Vista Energy
VIST
$7.57B
| $194K | ﹤0.01% |
6,393
-13,846
| -68% | -$362K |
|
5392
dLocal
DLO
$4.17B
| $194K | ﹤0.01% |
10,122
-30,752
| -75% | -$523K |
|
|
NCV
5393
Virtus Convertible & Income Fund
NCV
$392M
| $194K | ﹤0.01% |
15,575
-3,435
| -18% | -$45.8K |
|
5394
Invesco DB Energy Fund
DBE
$91.1M
| $194K | ﹤0.01% |
8,271
+290
| +4% | +$6.48K |
|
5395
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$321M
| $193K | ﹤0.01% |
195
-4
| -2% | -$3.54K |
|
|
SRV
5396
NXG Cushing Midstream Energy Fund
SRV
$226M
| $193K | ﹤0.01% |
5,317
+366
| +7% | +$14.9K |
|
5397
Nature's Sunshine
NATR
$266M
| $193K | ﹤0.01% |
11,628
+1,946
| +20% | +$29.6K |
|
|
AUTL
5398
Autolus Therapeutics
AUTL
$572M
| $192K | ﹤0.01% |
82,310
+12,217
| +17% | +$34.8K |
|
|
WSR
5399
DELISTED
Whitestone REIT
WSR
| $192K | ﹤0.01% |
19,914
-22,166
| -53% | -$221K |
|
|
CVGW
5400
DELISTED
Calavo Growers
CVGW
| $191K | ﹤0.01% |
7,574
-6,402
| -46% | -$208K |
|
Similar funds
UBS Group's Q3 2023 Portfolio in Review
As of Q3 2023, UBS Group held 10,416 positions worth $290B, down 2% from $296B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q3 2023 filing shows 1,615 new, 3,254 increased, 4,100 reduced and 999 closed positions. Its largest new stake was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M. The largest sale was NVIDIA, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2023 buy was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M.
- UBS Group added most to Invesco QQQ Trust in Q3 2023, an estimated $440M increase.
- UBS Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $538M.
- UBS Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $245M.
- UBS Group's ten largest holdings make up 15% of its $290B portfolio in Q3 2023.
- UBS Group opened 1,615 new positions and closed 999 in Q3 2023.
- UBS Group's portfolio value fell 2% quarter-over-quarter to $290B.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.